Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Horm Behav. 2021 Jun 23;133:105008. doi: 10.1016/j.yhbeh.2021.105008

Fig. 5. HIV-1 Tat and morphine did not alter serum corticosterone or PFC, hippocampus, or amygdala corticotropin releasing factor (CRF) expression.

Fig. 5.

Mice that were behaviorally tested in assays of sociability after 8 weeks of Tat and 2 weeks of morphine exposure did not exhibit altered levels of CRF in the PFC (A), amygdala (B), or hippocampus (C) of behaviorally-tested mice as measured by western blotting. Tat and morphine also did not alter serum corticosterone levels (D). All CRF western blots are represented as relative intensity to GAPDH normalized to Tat(−)/Saline. Data are presented as mean ± SEM; n = 9-10 mice per group.